share_log

Quanex Building Products Corporation Reports Strong Year-End Results Driven by Tyman Acquisition

Quiver Quantitative ·  12/13 05:21

Quanex Building Products reported increased net sales and integration progress post-Tyman acquisition, despite margin pressures and net losses.

Quiver AI Summary

Quanex Building Products Corporation reported strong financial results for the fiscal year ending October 31, 2024, driven by the successful acquisition of Tyman. Net sales rose 66.6% year-over-year in Q4 to $492.2 million, with total sales for the year reaching $1.28 billion, a 13.0% increase. However, net income for the year was $33.1 million, significantly lower than the previous year's $82.5 million, reflecting a net loss of $13.9 million in the fourth quarter. The company has made progress in integrating Tyman ahead of schedule and has repaid $53.75 million in debt since closing the acquisition. Looking ahead, Quanex expects to navigate ongoing demand softness but anticipates improvement in the second half of 2025, supported by seasonal trends and improved consumer confidence. The company also plans to provide details on its new operating structure and growth strategy during an Investor and Analyst Day on February 6, 2025.

Potential Positives

  • Net sales increased by 66.6% year-over-year for the fourth quarter and 13.0% for the full year, significantly boosted by the integration of the Tyman acquisition.
  • About $54 million of debt was repaid since the Tyman acquisition, improving the company's balance sheet and financial stability.
  • Margin expansion was achieved on a consolidated basis for the full year, driven by effective cost control and synergies from the Tyman acquisition.
  • The company scheduled an Investor and Analyst Day for February 6, 2025, to provide updates on its operational strategy and performance, indicating proactive investor communication and engagement.

Potential Negatives

  • Despite a 66.6% increase in net sales due to the Tyman acquisition, excluding Tyman, net sales would have declined by 2.3% for the fourth quarter and 5.0% for the full year, indicating underlying sales weaknesses in the legacy segments.
  • The company reported a net loss of $13.9 million for the fourth quarter of 2024, contrasting sharply with a profit of $27.4 million in the prior year, and net income for the full year also fell significantly from $82.5 million to $33.1 million.
  • Free cash flow was negative at ($8.2 million) for the quarter and decreased significantly year-over-year, suggesting potential liquidity challenges despite efforts to manage working capital and repay debt.

FAQ

What were Quanex's net sales for the fourth quarter of 2024?

Quanex reported net sales of $492.2 million for the fourth quarter of 2024, a 66.6% increase from the previous year.

How much debt has Quanex repaid since acquiring Tyman?

Since acquiring Tyman on August 1, 2024, Quanex has repaid approximately $53.75 million in debt.

What were the adjusted earnings for Quanex in 2024?

Quanex reported adjusted net income of $28.6 million and adjusted diluted EPS of $0.61 for the third quarter ended October 31, 2024.

When will Quanex hold its Investor and Analyst Day?

Quanex will host its Investor and Analyst Day on February 6, 2025, at the New York Stock Exchange.

How did Quanex's gross margin change in 2024?

Quanex's gross margin for the full year 2024 was $305.6 million, reflecting effective cost control and improved margins from the Tyman acquisition.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


$NX Insider Trading Activity

$NX insiders have traded $NX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here's a breakdown of recent trading of $NX stock by insiders over the last 6 months:

  • GEORGE LAVERNE WILSON (President & CEO) sold 6,300 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$NX Hedge Fund Activity

We have seen 150 institutional investors add shares of $NX stock to their portfolio, and 86 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • BLACKROCK, INC. added 2,080,234 shares (+39.5%) to their portfolio in Q3 2024
  • VANGUARD GROUP INC added 1,513,032 shares (+40.9%) to their portfolio in Q3 2024
  • PACER ADVISORS, INC. removed 1,295,125 shares (-100.0%) from their portfolio in Q3 2024
  • ARTEMIS INVESTMENT MANAGEMENT LLP added 552,909 shares (+inf%) to their portfolio in Q3 2024
  • LSV ASSET MANAGEMENT removed 372,748 shares (-43.4%) from their portfolio in Q3 2024
  • ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 362,763 shares (+164.9%) to their portfolio in Q3 2024
  • STATE STREET CORP added 351,778 shares (+28.1%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release




Contribution from Tyman Acquisition Boosts Results


Margin Expansion Realized on Consolidated Basis for Full Year


$53.75 Million of Debt Repaid Since Closing Tyman Acquisition


Integration of Transformative Acquisition Progressing Ahead of Schedule


Realization of Synergies Ongoing



HOUSTON, Dec. 12, 2024 (GLOBE NEWSWIRE) --



Quanex Building Products Corporation



(NYSE:NX) ("Quanex" or the "Company") today announced its results for the three months and twelve months ended October 31, 2024.



The Company reported the following selected financial results:



























































































































































































Three Months Ended October 31,




Twelve Months Ended October 31,


($ in millions, except per share data)




2024




2023




2024




2023


Net Sales



$492.2


$295.5


$1,277.9


$1,130.6

Gross Margin



$117.1


$80.0


$305.6


$277.5


Gross Margin %





23.8


%




27.1


%




23.9


%




24.5


%


Net (Loss) Income



($13.9)


$27.4


$33.1


$82.5

Diluted EPS



($0.30)


$0.83


$0.90


$2.50











Adjusted Net Income



$28.6


$31.2


$80.4


$90.9

Adjusted Diluted EPS



$0.61


$0.95


$2.19


$2.75

Adjusted EBITDA



$81.1


$50.8


$182.4


$159.6


Adjusted EBITDA Margin %





16.5


%




17.2


%




14.3


%




14.1


%












Cash Provided by Operating Activities



$5.5


$44.5


$88.8


$147.1

Free Cash Flow



($8.2)


$29.6


$51.7


$109.7

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)


George Wilson, Chairman, President and Chief Executive Officer, commented, "On a consolidated basis, results for the fourth quarter and full year were boosted by the contribution from the Tyman acquisition. Results from the legacy Quanex business were in-line with our expectations for both the fourth quarter and full year. We are pleased with profitability despite the soft macro environment we experienced throughout 2024. Overall, we executed on our plan from an operational standpoint, and we executed on our long-term profitable growth strategy by closing on the transformative Tyman acquisition in August. In addition, our continued focus on cash flow and managing working capital enabled us to repay approximately $54 million in debt since closing the acquisition on August 1, 2024.



"As we transition into 2025, we expect the current demand softness to persist until the spring selling season, but our expectations are that results will improve in the second half of 2025 due to typical seasonality combined with the benefit from unwinding pent up demand as interest rates continue to trend lower and consumer confidence improves. We will continue to focus on integrating the legacy Tyman business and capturing the targeted synergies. We have also settled on a new operating structure that is designed around our core competencies, which should enable us to capitalize on existing commercial opportunities and tap into new innovative solutions. Furthermore, we continue to be excited about building a stronger, more profitable company over time and creating additional value for our shareholders. We have scheduled an Investor and Analyst Day on February 6, 2025, to unveil the 'new' Quanex, which will include providing detail on the revamped operating structure, guidance for 2025 and an update on our long-term profitable growth strategy."




Fourth Quarter and Fiscal 2024 Results Summary



Quanex reported net sales of $492.2 million during the three months ended October 31, 2024, which represents an increase of 66.6% compared to $295.5 million for the same period of 2023. The Company reported net sales of $1.28 billion during the twelve months ended October 31, 2024, which represents an increase of 13.0% compared to $1.13 billion for the same period of 2023. The increases reflect the contribution from the Tyman acquisition that closed on August 1, 2024. Excluding the contribution from Tyman, net sales would have declined by 2.3% for the fourth quarter of 2024 and 5.0% for the full year, largely due to lower volume. Quanex reported a decline in net sales of 4.7% for the fourth quarter of 2024 and a decline of 2.6% in net sales for the full year in its North American Fenestration segment. In its North American Cabinet Components segment, Quanex reported an increase of 1.7% in net sales for the fourth quarter and a decline of 7.9% in net sales for the full year. Excluding foreign exchange impact, the Company realized a decrease in net sales of 1.2% for the fourth quarter and a decrease of 8.9% in net sales for the full year in its European Fenestration segment. In addition, Quanex reported net sales of $203.4 million related to the Tyman acquisition during the fourth quarter of 2024. (See Sales Analysis table for additional information)



The increase in adjusted earnings for the three months and twelve months ended October 31, 2024 was mostly attributable to the contribution from the Tyman acquisition; however, the increase in adjusted earnings was also due in part to the lower cost of sales, including labor, related to lower volumes and deflation in the price of raw materials. Quanex was able to realize margin expansion in the fourth quarter in its North American Fenestration segment mainly due to effective cost control. In addition, the Company was also able to realize margin expansion on a consolidated basis for the full year, primarily driven by the contribution from the Tyman acquisition.




Balance Sheet & Liquidity Update



The Company borrowed $770 million ($500 Term Loan A and $270 on Senior Secured Revolving Credit Facility) to acquire Tyman on August 1, 2024. Quanex repaid $53.75 million in debt during the fourth quarter of 2024. As of October 31, 2024, the Company had total debt of $776.9 million and Quanex's leverage ratio of Net Debt to LTM Adjusted EBITDA was 3.7x. As of October 31, 2024, the Company's LTM Net Income was $33.1 million and LTM Adjusted EBITDA was $182.4 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)



The leverage ratio for Quanex's quarterly debt covenant compliance ("Debt Covenant Leverage Ratio") for its lenders was 2.3x as of October 31, 2024. The Debt Covenant Leverage Ratio calculation is defined in the Company's Amendment No. 1 to its Second Amended and Restated Credit Agreement, which was filed with the SEC on June 12, 2024. In general, the main difference is that the Debt Covenant Leverage Ratio excludes real-estate leases that are considered "finance" leases under U.S. GAAP and is calculated on a proforma basis to include Adjusted EBITDA from the Tyman acquisition, $30 million of EBITDA for the synergy target related to the acquisition and only cash from domestic subsidiaries. The Debt Covenant Leverage Ratio would be 2.1x if calculated using the cash and cash equivalents amount on the balance sheet as of October 31, 2024.



Quanex's liquidity was $343.3 million as of October 31, 2024, consisting of $97.7 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.




Investor and Analyst Day



The Company announced it will host an Investor and Analyst Day at the New York Stock Exchange, 11 Wall St. New York, NY 1005, on February 6, 2025. The event will begin at 9:00 a.m. ET and conclude at approximately 11:00 a.m. ET. All investors and analysts that plan to attend should RSVP for the event by January 23, 2025, by contacting Quanex's Senior Vice President, Chief Financial Officer & Treasurer, Scott Zuehlke, by email (

scott.zuehlke@quanex.com

).



Presentation content and a live audio webcast will be made available on Quanex's website at



in the Investors section under Events & Presentations. A replay of the webcast will be posted following the live event.




Conference Call and Webcast Information



The Company has also scheduled a conference call for Friday, December 13, 2024 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex's website at



in the Investors section under Presentations & Events.



Participants can pre-register for the conference call using the following link:





Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company's website at



in the Investors section under Presentations & Events.




About Quanex



Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.




Non-GAAP Terminology Definitions and Disclaimers



Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex's leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company's credit agreement.



Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company's residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company's financial and cash management performance.



Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company's financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.




Forward Looking Statements



Statements that use the words "estimated," "expect," "could," "should," "believe," "will," "might," or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics) on the economy and the demand for Quanex's products, timing estimates or any other expectations related to the Acquisition, the Company's future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex's industry, and the Company's future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex's future performance, please refer to the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2023, and the Company's Quarterly Reports on Form 10-Q under the sections entitled "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors". Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.





























































































































































































































































































































































































































CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)
(Unaudited)













Three Months Ended October 31,




Twelve Months Ended October 31,






2024






2023






2024






2023












Net sales


$

492,161



$

295,492



$

1,277,862



$

1,130,583


Cost of sales



375,111




215,473




972,238




853,059


Selling, general and administrative



86,891




29,326




190,470




123,957


Depreciation and amortization



27,329




11,194




60,328




42,866


Operating income



2,830




39,499




54,826




110,701


Interest expense



(17,697

)



(1,565

)



(20,593

)



(8,136

)

Other, net



(2,671

)



(6,110

)



7,849




(5,519

)

(Loss) income before income taxes



(17,538

)



31,824




42,082




97,046


Income tax benefit (expense)



3,621




(4,442

)



(9,023

)



(14,545

)

Net (loss) income


$

(13,917

)


$

27,382



$

33,059



$

82,501











(Loss) earnings per common share, basic

$

(0.30

)


$

0.84



$

0.91



$

2.51


(Loss) earnings per common share, diluted

$

(0.30

)


$

0.83



$

0.90



$

2.50











Weighted average common shares outstanding:








Basic



47,015




32,753




36,416




32,819


Diluted



47,015




32,991




36,648




33,026











Cash dividends per share


$

0.08



$

0.08



$

0.32



$

0.32





















































































































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION


CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)
(Unaudited)











October 31, 2024




October 31, 2023



ASSETS






Current assets:





Cash and cash equivalents


$

97,744



$

58,474


Restricted Cash



5,251




-


Accounts receivable, net



197,689




97,311


Inventories



275,550




97,959


Income taxes receivable



5,937




8,298


Prepaid and other current assets



29,097




11,558


Total current assets



611,268




273,600


Property, plant and equipment, net



402,466




250,664


Operating lease right-of-use assets



126,715




46,620


Deferred tax assets



3,845




-


Goodwill



574,711




182,956


Intangible assets, net



597,909




74,115


Other assets



2,874




3,188


Total assets


$

2,319,788



$

831,143








LIABILITIES AND STOCKHOLDERS' EQUITY






Current liabilities:





Accounts payable


$

124,404



$

74,371


Accrued liabilities



103,623




50,319


Income taxes payable



6,620




384


Current maturities of long-term debt



25,745




2,365


Current operating lease liabilities



12,475




7,224


Total current liabilities



272,867




134,663


Long-term debt



737,198




66,435


Noncurrent operating lease liabilities



117,560




40,361


Deferred income taxes



162,304




29,133


Liabilities for uncertain tax positions



-




250


Other liabilities



19,113




14,747


Total liabilities



1,309,042




285,589


Stockholders' equity:





Common stock



513




372


Additional paid-in-capital



701,008




251,576


Retained earnings



430,405




409,318


Accumulated other comprehensive loss



(46,428

)



(38,141

)

Treasury stock at cost



(74,752

)



(77,571

)

Total stockholders' equity



1,010,746




545,554


Total liabilities and stockholders' equity


$

2,319,788



$

831,143































































































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(In thousands)
(Unaudited)







Twelve Months Ended October 31,





2024






2023




Operating activities:





Net income

$

33,059



$

82,501


Adjustments to reconcile net income to cash provided by operating activities:




Depreciation and amortization


60,328




42,866


(Gain) loss on disposition of capital assets


(5,218

)



278


Stock-based compensation


2,952




2,521


Deferred income tax


(15,336

)



5,147


Charge for deferred loan costs and debt discount


3,469




-


Gain on deal contingent foreign exchange forward currency contract


(6,512

)



-


Other, net


4,495




1,529


Changes in assets and liabilities:




Decrease in accounts receivable


973




6,969


Decrease in inventory


33,484




30,024


Decrease (increase) in other current assets


4,297




(1,880

)

Decrease in accounts payable


(35,824

)



(11,611

)

Increase (decrease) in accrued liabilities


6,250




(4,249

)

Increase (decrease) in income taxes receivable


9,139




(9,009

)

(Decrease) increase in other long-term liabilities


(7,155

)



683


Other, net


411




1,283


Cash provided by operating activities


88,812




147,052



Investing activities:





Business acquisition


(848,614

)



(91,302

)

Capital expenditures


(37,086

)



(37,390

)

Proceeds from disposition of capital assets


15,046




253


Cash used for investing activities


(870,654

)



(128,439

)


Financing activities:





Borrowings under credit facilities


785,000




102,000


Repayments of credit facility borrowings


(83,750

)



(100,000

)

Debt issuance costs


(13,808

)



-


Borrowings (repayments) of other long-term debt


(296,206

)



(2,567

)

Issuance of common stock


450,633




1,215


Proceeds from deal contingent foreign exchange forward currency contract


6,512




-


Common stock dividends paid


(11,972

)



(10,639

)

Payroll tax paid to settle shares forfeited upon vesting of stock


(1,193

)



(567

)

Purchase of treasury stock


-




(5,593

)

Cash provided (used for) by financing activities


835,216




(16,151

)

Effect of exchange rate changes on cash and cash equivalents


(8,853

)



919


Increase in cash, cash equivalents and restricted cash


44,521




3,381


Cash, cash equivalents and restricted cash at beginning of period


58,474




55,093


Cash, cash equivalents and restricted cash at end of period

$

102,995



$

58,474






















































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION


FREE CASH FLOW AND NET DEBT RECONCILIATION

(In thousands)
(Unaudited)













The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

















Three Months Ended October 31,




Twelve Months Ended October 31,







2024




2023




2024




2023



Cash provided by operating activities



$5,479


$44,493


$88,812


$147,052


Capital expenditures



(13,651)


(14,940)


(37,086)


(37,390)



Free Cash Flow





($8,172)




$29,553




$51,726




$109,662

























The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

















As of October 31,









2024




2023







Term loan facility



$493,750


$0






Revolving credit facility



222,500


15,000






Finance lease obligations

(1)




60,676


55,000






Total debt

(2)




776,926


70,000






Less: Cash and cash equivalents



97,744


58,474







Net Debt





$679,182




$11,526


















(1) Includes $50.3 million and $51.5 million in real estate lease liabilities considered finance leases under U.S. GAAP as of October 31, 2024 and October 31, 2023, respectively.


(2) Excludes outstanding letters of credit.







































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION


NON-GAAP FINANCIAL MEASURE DISCLOSURE


LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION

(In thousands, except per share data)
(Unaudited)













Reconciliation of Last Twelve Months Adjusted EBITDA




Three Months Ended October 31, 2024




Three Months Ended July 31, 2024




Three Months Ended April 30, 2024




Three Months Ended January 31, 2024




Total





Reconciliation




Reconciliation




Reconciliation




Reconciliation




Reconciliation


Net (loss) income as reported


$

(13,917

)


$

25,350



$

15,377



$

6,249



$

33,059


Income tax (benefit) expense



(3,621

)



6,688




4,314




1,642




9,023


Other, net



2,671




(9,474

)



(4

)



(1,042

)



(7,849

)

Interest expense



17,697




878




950




1,068




20,593


Depreciation and amortization



27,329




10,953




10,894




11,152




60,328


EBITDA



30,159




34,395




31,531




19,069




115,154


Cost of sales

(1),(2)




887




1,507




631




-




3,025


Selling, general and administrative

(1),(2),(3),(4)




50,004




6,133




7,862




205




64,204


Adjusted EBITDA


$

81,050



$

42,035



$

40,024



$

19,274



$

182,383













(1) Expense (gain) related to plant closure.



(2) Loss on damage to manufacturing facilities caused by weather.

(3) Transaction and advisory fees.

(4) Amortization of step-up for purchase price adjustments on inventory and accounts receivable.































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION


NON-GAAP FINANCIAL MEASURE DISCLOSURE

(In thousands, except per share data)
(Unaudited)




















Reconciliation of Adjusted Net Income and Adjusted EPS



Three Months Ended
October 31, 2024




Three Months Ended
October 31, 2023




Twelve Months Ended
October 31, 2024




Twelve Months Ended
October 31, 2023






Net Income




Diluted EPS




Net Income




Diluted EPS




Net Income




Diluted EPS




Net Income




Diluted EPS



Net (loss) income as reported


$

(13,917

)


$

(0.30

)


$

27,382



$

0.83



$

33,059



$

0.90



$

82,501



$

2.50



Net (loss) income reconciling items from below



42,528



$

0.91




3,851



$

0.12




47,303



$

1.29




8,401



$

0.25



Adjusted net income and adjusted EPS


$

28,611



$

0.61



$

31,233



$

0.95



$

80,362



$

2.19



$

90,902



$

2.75






















Reconciliation of Adjusted EBITDA




Three Months Ended
October 31, 2024




Three Months Ended
October 31, 2023




Twelve Months Ended
October 31, 2024




Twelve Months Ended
October 31, 2023






Reconciliation






Reconciliation






Reconciliation






Reconciliation





Net (loss) income as reported


$

(13,917

)




$

27,382





$

33,059





$

82,501





Income tax (benefit) expense



(3,621

)





4,442






9,023






14,545





Other, net



2,671






6,110






(7,849

)





5,519





Interest expense



17,697






1,565






20,593






8,136





Depreciation and amortization



27,329






11,194






60,328






42,866





EBITDA



30,159






50,693






115,154






153,567





EBITDA reconciling items from below



50,891






74






67,229






6,028





Adjusted EBITDA


$

81,050





$

50,767





$

182,383





$

159,595
























Reconciling Items




Three Months Ended
October 31, 2024




Three Months Ended
October 31, 2023




Twelve Months Ended
October 31, 2024




Twelve Months Ended
October 31, 2023






Income Statement




Reconciling Items




Income Statement




Reconciling Items




Income Statement




Reconciling Items




Income Statement




Reconciling Items



Net sales


$

492,161



$

-



$

295,492



$

-



$

1,277,862



$

-



$

1,130,583



$

-



Cost of sales



375,111




(887

)



(1)




215,473




35




(2)




972,238




(3,025

)



(1)




853,059




(13

)



(2)



Selling, general and administrative



86,891




(50,004

)



(1),(3),(4)




29,326




(109

)



(2),(3)




190,470




(64,204

)



(1),(3),(4)




123,957




(6,015

)



(2),(3)



EBITDA



30,159




50,891




50,693




74




115,154




67,229




153,567




6,028



Depreciation and amortization



27,329




-




11,194




-




60,328




-




42,866




-



Operating income



2,830




50,891




39,499




74




54,826




67,229




110,701




6,028



Interest expense



(17,697

)



-




(1,565

)



-




(20,593

)



-




(8,136

)



-



Other, net



(2,671

)



3,271




(5)




(6,110

)



5,232




(5)




7,849




(6,738

)



(5)




(5,519

)



5,196




(5)



(Loss) Income before income taxes



(17,538

)



54,162




31,824




5,306




42,082




60,491




97,046




11,224



Income tax benefit (expense)



3,621




(11,634

)



(6)




(4,442

)



(1,455

)



(6)




(9,023

)



(13,188

)



(6)




(14,545

)



(2,823

)



(6)



Net (loss) income


$

(13,917

)


$

42,528



$

27,382



$

3,851



$

33,059



$

47,303



$

82,501



$

8,401





















Diluted (loss) earnings per share


$

(0.30

)




$

0.83





$

0.90





$

2.50









































(1) (Expense) gain related to plant closure.


(2) Loss on damage to manufacturing facilities caused by weather.


(3) Transaction and advisory fees.


(4) Amortization of step-up for purchase price adjustments on inventory and accounts receivable.


(5) Pension settlement (refund) expense, losses (gains) on foreign exchange forward currency contract and foreign currency transaction losses (gains).


(6)Tax impact of net income reconciling items.





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION


SELECTED SEGMENT DATA

(In thousands)
(Unaudited)














This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.




NA Fenestration




EU Fenestration




NA Cabinet Components




Tyman




Unallocated Corp & Other




Total



Three months ended October 31, 2024














Net sales


$

172,031



$

65,075



$

52,761



$

203,435



$

(1,141

)


$

492,161


Cost of sales



127,448




40,258




44,136




163,946




(677

)



375,111


Gross Margin



44,583




24,817




8,625




39,489




(464

)



117,050



Gross Margin %





25.9


%






38.1


%






16.3


%






19.4


%








23.8


%



Selling, general and administrative

(1)




10,072




8,310




5,373




44,453




18,683




86,891


Depreciation and amortization



5,107




2,715




3,004




16,438




65




27,329


Operating income (loss)



29,404




13,792




248




(21,402

)



(19,212

)



2,830


Depreciation and amortization



5,107




2,715




3,004




16,438




65




27,329


EBITDA



34,511




16,507




3,252




(4,964

)



(19,147

)



30,159


Expense related to plant closure (Cost of sales)



887




-




-




-




-




887


Net gain related to plant closure (SG&A)



(5,299

)



-




-




-




-




(5,299

)

Amortization of step-up for purchase price adjustments on inventory and accounts receivable



-




-




-




29,076




-




29,076


Transaction and advisory fees



-




-




-




10,359




15,868




26,227


Adjusted EBITDA


$

30,099



$

16,507



$

3,252



$

34,471



$

(3,279

)


$

81,050



Adjusted EBITDA Margin %





17.5


%






25.4


%






6.2


%






16.9


%








16.5


%

















Three months ended October 31, 2023














Net sales


$

180,446



$

64,170



$

51,868



$

-



$

(992

)


$

295,492


Cost of sales



135,490




39,070




41,488




-




(575

)



215,473


Gross Margin



44,956




25,100




10,380




-




(417

)



80,019



Gross Margin %





24.9


%






39.1


%






20.0


%










27.1


%



Selling, general and administrative

(1)




15,272




8,354




5,135




-




565




29,326


Depreciation and amortization



5,211




2,714




3,220




-




49




11,194


Operating income (loss)



24,473




14,032




2,025




-




(1,031

)



39,499


Depreciation and amortization



5,211




2,714




3,220




-




49




11,194


EBITDA



29,684




16,746




5,245




-




(982

)



50,693


Loss on damage to manufacturing facilities (Cost of sales)



(35

)



-




-




-




-




(35

)

Loss on damage to manufacturing facilities (SG&A)



-




-




(131

)



-




-




(131

)

Transaction and advisory fees



-




-




-




-




240




240


Loss on sale of plant



-




-




-




-




-




-


Adjusted EBITDA


$

29,649



$

16,746



$

5,114



$

-



$

(742

)


$

50,767



Adjusted EBITDA Margin %





16.4


%






26.1


%






9.9


%










17.2


%

















Twelve months ended October 31, 2024














Net sales


$

650,058



$

230,712



$

198,424



$

203,435



$

(4,767

)


$

1,277,862


Cost of sales



498,378




144,585




168,414




163,946




(3,085

)



972,238


Gross Margin



151,680




86,127




30,010




39,489




(1,682

)



305,624



Gross Margin %





23.3


%






37.3


%






15.1


%






19.4


%








23.9


%



Selling, general and administrative

(1)




56,630




31,318




20,727




44,453




37,342




190,470


Depreciation and amortization



20,994




10,420




12,244




16,438




232




60,328


Operating income (loss)



74,056




44,389




(2,961

)



(21,402

)



(39,256

)



54,826


Depreciation and amortization



20,994




10,420




12,244




16,438




232




60,328


EBITDA



95,050




54,809




9,283




(4,964

)



(39,024

)



115,154


Expense related to plant closure (Cost of sales)



3,025




-




-




-




-




3,025


Net gain related to plant closure (SG&A)



(4,196

)



-




-




-




-




(4,196

)

Amortization of step-up for purchase price adjustments on inventory and accounts receivable



-




-




-




29,076




-




29,076


Transaction and advisory fees



-




-




-




10,359




28,965




39,324


Adjusted EBITDA


$

93,879



$

54,809



$

9,283



$

34,471



$

(10,059

)


$

182,383



Adjusted EBITDA Margin %





14.4


%






23.8


%






4.7


%






16.9


%








14.3


%

















Twelve months ended October 31, 2023














Net sales


$

667,482



$

250,774



$

215,445



$

-



$

(3,118

)


$

1,130,583


Cost of sales



517,805




158,491




178,210




-




(1,447

)



853,059


Gross Margin



149,677




92,283




37,235




-




(1,671

)



277,524



Gross Margin %





22.4


%






36.8


%






17.3


%










24.5


%



Selling, general and administrative

(1)




56,979




32,350




21,074




-




13,554




123,957


Depreciation and amortization



20,539




9,849




12,208




-




270




42,866


Operating income (loss)



72,159




50,084




3,953




-




(15,495

)



110,701


Depreciation and amortization



20,539




9,849




12,208




-




270




42,866


EBITDA



92,698




59,933




16,161




-




(15,225

)



153,567


Loss on damage to manufacturing facilities (Cost of sales)



-




-




13




-




-




13


Loss on damage to manufacturing facilities (SG&A)



-




-




69




-




-




69


Transaction and advisory fees



-




-




-




-




5,946




5,946


Adjusted EBITDA


$

92,698



$

59,933



$

16,243



$

-



$

(9,279

)


$

159,595



Adjusted EBITDA Margin %





13.9


%






23.9


%






7.5


%










14.1


%
















(1) Includes stock-based compensation expense for the three and twelve months ended October 31, 2024 of $2.0 million and $1.7 million, respectively, and $7.4 million and $9.3 million for the comparable prior year periods.

























































































































































































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION


SALES ANALYSIS

(In thousands)
(Unaudited)













Three Months Ended October 31,




Twelve Months Ended October 31,






2024






2023






2024






2023













NA Fenestration:










United States - fenestration

$

128,633



$

138,783



$

491,307



$

518,396



International - fenestration


9,323




8,081




29,882




30,100



United States - non-fenestration


29,050




29,267




110,246




103,090



International - non-fenestration


5,025




4,315




18,623




15,896




$

172,031



$

180,446



$

650,058



$

667,482



EU Fenestration:



(1)











International - fenestration

$

54,665



$

49,862



$

193,935



$

191,871



International - non-fenestration


10,410




14,308




36,777




58,903




$

65,075



$

64,170



$

230,712



$

250,774



NA Cabinet Components:










United States - fenestration

$

3,710



$

4,286



$

14,913



$

16,899



United States - non-fenestration


49,038




47,092




182,494




195,866



International - non-fenestration


13




490




1,017




2,680




$

52,761



$

51,868



$

198,424



$

215,445



Tyman:










United States - fenestration

$

127,749



$

-



$

127,749



$

-



International - fenestration


75,082




-




75,082




-



United States - non-fenestration


604




-




604




-




$

203,435



$

-



$

203,435



$

-












Unallocated Corporate & Other:










Eliminations

$

(1,141

)


$

(992

)


$

(4,767

)


$

(3,118

)



$

(1,141

)


$

(992

)


$

(4,767

)


$

(3,118

)











Net Sales


$

492,161



$

295,492



$

1,277,862



$

1,130,583











(1) Reflects an increase of $1.7 million and $2.5 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2024, respectively.


これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする